{
  "DOI": "10.1038/ejhg.2011.109",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2011.109",
  "alternative-id": [
    "BFejhg2011109"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Berthels",
      "given": "Nele",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Matthijs",
      "given": "Gert",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Van Overwalle",
      "given": "Geertrui",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        8,
        3
      ]
    ],
    "date-time": "2011-08-03T20:48:12Z",
    "timestamp": 1312404492000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:02:38Z",
    "timestamp": 1684429358000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        15
      ]
    ],
    "date-time": "2023-09-15T02:25:55Z",
    "timestamp": 1694744755775
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "11",
  "issued": {
    "date-parts": [
      [
        2011,
        8,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "11",
    "published-print": {
      "date-parts": [
        [
          2011,
          11
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            8,
            3
          ]
        ],
        "date-time": "2011-08-03T00:00:00Z",
        "timestamp": 1312329600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2011109.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2011109",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2011109.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1114-1121",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2011,
        8,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        8,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        11
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/458405a",
      "author": "R Cook-Deegan",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "124 suppl",
      "journal-title": "Nature",
      "key": "BFejhg2011109_CR1",
      "unstructured": "Cook-Deegan R, Chandrasekharan S, Angrist M : The dangers of diagnostic monopolies. Nature 2009; 458: 405–406. Also see the case studies carried out by Cook-Deegan and his team: Patently Complicated: Case studies on the impact of patenting and licensing on clinical access to genetic testing in the United States. Genet Med 2010; 12(4 suppl): S1–S211.",
      "volume": "458",
      "year": "2009"
    },
    {
      "DOI": "10.1038/458407a",
      "author": "S Gaisser",
      "doi-asserted-by": "publisher",
      "first-page": "407",
      "journal-title": "Nature",
      "key": "BFejhg2011109_CR2",
      "unstructured": "Gaisser S, Hopkins MM, Liddell K, Zika E, Ibarreta D : The phantom menace of gene patents. Nature 2009; 458: 407–408.",
      "volume": "458",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nbt0707-739",
      "author": "J Kaye",
      "doi-asserted-by": "publisher",
      "first-page": "739",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR3",
      "unstructured": "Kaye J, Hawkins N, Taylor J : Patents and translational research in genomics. Nat Biotechnol 2007; 25: 739–741.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nbt0907-989",
      "author": "RD Klein",
      "doi-asserted-by": "publisher",
      "first-page": "989",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR4",
      "unstructured": "Klein RD : Gene patents and genetic testing in the United States. Nat Biotechnol 2007; 25: 989–990.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S1525-1578(10)60444-8",
      "author": "MK Cho",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "J Mol Diagn",
      "key": "BFejhg2011109_CR5",
      "unstructured": "Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF : Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3–8.",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10689-005-2580-6",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Fam Cancer",
      "key": "BFejhg2011109_CR6",
      "unstructured": "Matthijs G : The European opposition against the BRCA gene patents. Fam Cancer 2006; 5: 95–102.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200924",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "783",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2011109_CR7",
      "unstructured": "Matthijs G, Halley D : European-wide opposition against the breast cancer gene patents. Eur J Hum Genet 2002; 10: 783–785.",
      "volume": "10",
      "year": "2002"
    },
    {
      "key": "BFejhg2011109_CR8",
      "unstructured": "SACGHS: Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. SACGHS, NIH: Bethesda, MD, April 2010. Available at http://oba.od.nih.gov/oba/sacghs/reports/SACGHS_patents_report_2010.pdf ."
    },
    {
      "DOI": "10.1038/nbt1004-1230",
      "author": "D Ibarreta",
      "doi-asserted-by": "publisher",
      "first-page": "1230",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR9",
      "unstructured": "Ibarreta D, Elles R, Cassiman JJ, Rodriguez-Cerezo E, Dequeker E : Towards quality assurance and harmonization of genetic testing services in the European Union. Nat Biotechnol 2004; 22: 1230–1235.",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nbt0806-939",
      "author": "JH Barton",
      "doi-asserted-by": "publisher",
      "first-page": "939",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR10",
      "unstructured": "Barton JH : Emerging patent issues in genomic diagnostics. Nat Biotechnol 2006; 24: 939–941.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201484",
      "author": "JJ Cassiman",
      "doi-asserted-by": "publisher",
      "first-page": "1103",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2011109_CR11",
      "unstructured": "Cassiman JJ : Research network: EuroGentest - a European Network of Excellence aimed at harmonizing genetic testing services. Eur J Hum Genet 2005; 13: 1103–1105.",
      "volume": "13",
      "year": "2005"
    },
    {
      "key": "BFejhg2011109_CR12",
      "unstructured": "ACMG (American College of Medical Genetics): Standards and guidelines for clinical genetics laboratories 2007 edition. Available at http://www.acmg.net ."
    },
    {
      "DOI": "10.1038/nbt0207-185",
      "author": "MM Hopkins",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR13",
      "unstructured": "Hopkins MM, Mahdi S, Patel P, Thomas SM : DNA patenting: The end of an era? Nat Biotechnol 2007; 25: 185–187.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1126/science.1120014",
      "author": "K Jensen",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "journal-title": "Science",
      "key": "BFejhg2011109_CR14",
      "unstructured": "Jensen K, Murray F : Intellectual property landscape of the human genome. Science 2005; 310: 239–240.",
      "volume": "310",
      "year": "2005"
    },
    {
      "key": "BFejhg2011109_CR15",
      "unstructured": "Article 28 (1) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs Agreement), 1994 ( http://www.wto.org/english/docs_e/legal_e/27-trips.pdf )."
    },
    {
      "DOI": "10.1016/S1474-4422(04)00737-9",
      "author": "L Schöls",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "journal-title": "Lancet Neurol",
      "key": "BFejhg2011109_CR16",
      "unstructured": "Schöls L, Bauer P, Schmidt T, Schulte T, Riess O : Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291–304.",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1373/clinchem.2006.083360",
      "author": "KL Edlefsen",
      "doi-asserted-by": "publisher",
      "first-page": "1016",
      "journal-title": "Clin Chem",
      "key": "BFejhg2011109_CR17",
      "unstructured": "Edlefsen KL, Tait JF, Wener MH, Astion M : Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility. Clin Chem 2007; 53: 1016–1022.",
      "volume": "53",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201503",
      "author": "B Verbeure",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2011109_CR18",
      "unstructured": "Verbeure B, Matthijs G, Van Overwalle G : Analysing DNA patents in relation with diagnostic genetic testing. Eur J Hum Genet 2006; 14: 26–33.",
      "volume": "14",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nbt1009-903",
      "author": "I Huys",
      "doi-asserted-by": "publisher",
      "first-page": "903",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2011109_CR19",
      "unstructured": "Huys I, Berthels N, Matthijs G, Van Overwalle G : Legal uncertainty in the area of genetic diagnostic testing. Nat Biotechnol 2009; 27: 903–909.",
      "volume": "27",
      "year": "2009"
    },
    {
      "author": "WE Bird",
      "first-page": "75",
      "key": "BFejhg2011109_CR20",
      "unstructured": "Bird WE : Using the EPO opposition procedure as a strategy against patents on diagnostic methods; In: Van Overwalle (ed): Gene patents and Public Health. Brussels: Belgium, Bruylant, 2007; pp 75–78.",
      "volume-title": "Gene patents and Public Health",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/6.8.1289",
      "author": "O Riess",
      "doi-asserted-by": "publisher",
      "first-page": "1289",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2011109_CR21",
      "unstructured": "Riess O, Schöls L, Bottger H et al: SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. Hum Mol Genet 1997; 6: 1289–1293.",
      "volume": "6",
      "year": "1997"
    },
    {
      "DOI": "10.1038/nrg1765",
      "author": "G Van Overwalle",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Nat Rev Genet",
      "key": "BFejhg2011109_CR22",
      "unstructured": "Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G : Models for facilitating access to patents on genetic inventions. Nat Rev Genet 2006; 7: 143–148.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.2307/3480996",
      "author": "R Merges",
      "doi-asserted-by": "publisher",
      "first-page": "1293",
      "journal-title": "Calif Law Rev",
      "key": "BFejhg2011109_CR23",
      "unstructured": "Merges R : Contracting into liability rules: Intellectual property rights and collective rights organizations. Calif Law Rev 1996; 84: 1293–1293.",
      "volume": "84",
      "year": "1996"
    },
    {
      "author": "C Shapiro",
      "first-page": "119",
      "key": "BFejhg2011109_CR24",
      "unstructured": "Shapiro C : Navigating the patent thicket: Cross licenses, patent pools and standard setting; In Jaffe E, Lerner J, Stern S (eds): Innovation Policy and the Economy, (vol. 1.), Cambridge, MA: MIT Press, 2001, pp 119–150. Available at http://faculty.haas.berkeley.edu/shapiro/thicket.pdf .",
      "volume-title": "Innovation Policy and the Economy",
      "year": "2001"
    },
    {
      "author": "T Ebersole",
      "first-page": "1",
      "journal-title": "IP Techn Law J",
      "key": "BFejhg2011109_CR25",
      "unstructured": "Ebersole T, Guthrie M, Goldstein JA : Patent pools as a solution to the licensing problems of diagnostic genetics. IP Techn Law J 2005; 17: 1–8.",
      "volume": "17",
      "year": "2005"
    },
    {
      "key": "BFejhg2011109_CR26",
      "unstructured": "OECD: Guidelines for the licensing of genetic inventions. Available at www.oecd.org/sti/biotechnology/licensing ."
    },
    {
      "DOI": "10.1038/sj.ejhg.5201929",
      "author": "European Society of Human Genetics",
      "doi-asserted-by": "crossref",
      "first-page": "405",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2011109_CR27",
      "unstructured": "European Society of Human Genetics: Recommendations on patenting and licensing in genetic testing. Eur J Hum Genet 2008; 16: 405–411.",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1373/clinchem.2006.066654",
      "author": "H Azzazy",
      "doi-asserted-by": "publisher",
      "first-page": "1238",
      "journal-title": "Clin Chem",
      "key": "BFejhg2011109_CR28",
      "unstructured": "Azzazy H, Mansour M, Kazmierczak S : Nanodiagnostics: A new frontier for clinical laboratory medicine. Clin Chem 2006; 52: 1238–1246.",
      "volume": "52",
      "year": "2006"
    },
    {
      "DOI": "10.1002/mds.21228",
      "author": "A Modoni",
      "doi-asserted-by": "publisher",
      "first-page": "324",
      "journal-title": "Mov Disord",
      "key": "BFejhg2011109_CR29",
      "unstructured": "Modoni A, Contarino MF, Bentivoglio AR et al: Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord 2007; 22: 324–327.",
      "volume": "22",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nature09320",
      "author": "AC Elden",
      "doi-asserted-by": "publisher",
      "first-page": "1069",
      "journal-title": "Nature",
      "key": "BFejhg2011109_CR30",
      "unstructured": "Elden AC, Kim H-J, Hart MP et al: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466: 1069–1075.",
      "volume": "466",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s00439-003-0939-z",
      "author": "J Macpherson",
      "doi-asserted-by": "crossref",
      "first-page": "619",
      "journal-title": "Hum Genet",
      "key": "BFejhg2011109_CR31",
      "unstructured": "Macpherson J, Waghorn A, Hammans S, Jacobs P : Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 2003; 112: 619–620.",
      "volume": "112",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ncpneuro0606",
      "author": "SA Schneider",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "journal-title": "Nat Clin Pract",
      "key": "BFejhg2011109_CR32",
      "unstructured": "Schneider SA, Walker RH, Bhatia KP : The Huntington's disease-like syndromes: What to consider in patients with a negative Huntington's disease gene test. Nat Clin Pract 2007; 3: 517–525.",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1017/CBO9780511581182",
      "author": "G Van Overwalle",
      "doi-asserted-by": "publisher",
      "key": "BFejhg2011109_CR33",
      "unstructured": "Van Overwalle G (ed): Gene Patents and Collaborative Licensing Models. Patent Pools, Clearinghouses, Open Source Models and Liability Regimes. Cambridge: Cambridge University Press, 2009.",
      "volume-title": "Gene Patents and Collaborative Licensing Models. Patent Pools, Clearinghouses, Open Source Models and Liability Regimes",
      "year": "2009"
    },
    {
      "key": "BFejhg2011109_CR34",
      "unstructured": "Van Zimmeren E, Van Overwalle G : A Paper Tiger? Compulsory License Regimes for Public Health in Europe. International Review of Intellectual Property and Competition Law (IIC) 2011, 4–40"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2011109"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia"
  ],
  "type": "journal-article",
  "volume": "19"
}